GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » FCF Yield %

NervGen Pharma (NervGen Pharma) FCF Yield % : -6.88 (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NervGen Pharma's Trailing 12-Month Free Cash Flow is $-7.26 Mil, and Market Cap is $105.51 Mil. Therefore, NervGen Pharma's FCF Yield % for today is -6.88%.

The historical rank and industry rank for NervGen Pharma's FCF Yield % or its related term are showing as below:

NGENF' s FCF Yield % Range Over the Past 10 Years
Min: -16.76   Med: 0   Max: 0
Current: -6.88


NGENF's FCF Yield % is ranked better than
66.26% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs NGENF: -6.88

NervGen Pharma's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


NervGen Pharma FCF Yield % Historical Data

The historical data trend for NervGen Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma FCF Yield % Chart

NervGen Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -13.25 -8.04 -6.60 -18.74 -7.01

NervGen Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.17 -8.18 -5.03 -7.57 -8.52

Competitive Comparison of NervGen Pharma's FCF Yield %

For the Biotechnology subindustry, NervGen Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NervGen Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NervGen Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NervGen Pharma's FCF Yield % falls into.



NervGen Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NervGen Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.525 / 121.597056
=-7.01%

NervGen Pharma's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2.399 * 4 / 112.583597
=-8.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NervGen Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


NervGen Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NervGen Pharma (NervGen Pharma) Business Description

Traded in Other Exchanges
Address
2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

NervGen Pharma (NervGen Pharma) Headlines

From GuruFocus